Guozhen Hao

570 total citations
27 papers, 453 citations indexed

About

Guozhen Hao is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Guozhen Hao has authored 27 papers receiving a total of 453 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Cardiology and Cardiovascular Medicine, 9 papers in Surgery and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Guozhen Hao's work include Acute Myocardial Infarction Research (10 papers), Cardiac Imaging and Diagnostics (5 papers) and Chronic Kidney Disease and Diabetes (5 papers). Guozhen Hao is often cited by papers focused on Acute Myocardial Infarction Research (10 papers), Cardiac Imaging and Diagnostics (5 papers) and Chronic Kidney Disease and Diabetes (5 papers). Guozhen Hao collaborates with scholars based in China. Guozhen Hao's co-authors include Xinshun Gu, Yunfa Jiang, Weize Fan, Xianghua Fu, Shiqiang Li, Weili Wu, Xianghua Fu, Xinwei Jia, Xuechao Wang and Jing Zhang and has published in prestigious journals such as Journal of the American College of Cardiology, The American Journal of Cardiology and Catheterization and Cardiovascular Interventions.

In The Last Decade

Guozhen Hao

27 papers receiving 442 citations

Peers

Guozhen Hao
Xinshun Gu China
Xianghua Fu China
Hein A. Koomans Netherlands
Catherine B. Brouwer Netherlands
Xinwei Jia China
Jean‐Luc Magnin Switzerland
Abdullah Tekin Türkiye
Priyanka Kakar United States
Silvio Fedele Italy
Göknur Tekin Türkiye
Xinshun Gu China
Guozhen Hao
Citations per year, relative to Guozhen Hao Guozhen Hao (= 1×) peers Xinshun Gu

Countries citing papers authored by Guozhen Hao

Since Specialization
Citations

This map shows the geographic impact of Guozhen Hao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guozhen Hao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guozhen Hao more than expected).

Fields of papers citing papers by Guozhen Hao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guozhen Hao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guozhen Hao. The network helps show where Guozhen Hao may publish in the future.

Co-authorship network of co-authors of Guozhen Hao

This figure shows the co-authorship network connecting the top 25 collaborators of Guozhen Hao. A scholar is included among the top collaborators of Guozhen Hao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guozhen Hao. Guozhen Hao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Yanbo, et al.. (2022). The effect and mechanism of dl-3-n-butylphthalide on angiogenesis in a rat model of chronic myocardial ischemia. PubMed Central. 3 indexed citations
2.
Jiang, Yunfa, et al.. (2020). Safety and feasibility of low‐dose ticagrelor in patients with ST‐segment elevation myocardial infarction. Clinical Cardiology. 44(1). 123–128. 4 indexed citations
3.
4.
Zhao, Ying, Haiyan Wang, Jiayu Zhao, et al.. (2020). Renal protective effect of sodium ferulate on pulmonary hypertension patients undergoing computed tomography pulmonary angiography. Pulmonary Circulation. 10(4). 1–7. 1 indexed citations
5.
Hao, Guozhen, Yunfa Jiang, Xianghua Fu, et al.. (2019). Effects of Levosimendan on Right Ventricular Function in Patients with Acute Decompensated Heart Failure.. PubMed. 35(6). 585–591. 9 indexed citations
6.
Hao, Guozhen, Yunfa Jiang, Xianghua Fu, et al.. (2018). GW29-e1222 Effects of levosimendan on right ventricular function in patients with acute decompensated heart failure. Journal of the American College of Cardiology. 72(16). C167–C167. 1 indexed citations
7.
Fu, Xianghua, Xinshun Gu, Weize Fan, et al.. (2017). Effects of intensive pitavastatin therapy on glucose control in patients with non-ST elevation acute coronary syndrome.. PubMed. 7(4). 89–96. 6 indexed citations
8.
Fu, Xianghua, Xinshun Gu, Guozhen Hao, et al.. (2015). Effect of rhBNP on renal function in STEMI-HF patients with mild renal insufficiency undergoing primary PCI. Heart and Vessels. 31(4). 490–498. 16 indexed citations
9.
Fu, Xianghua, Lingling Jiang, Wei Li, et al.. (2015). Cardioprotective Effect of Anisodamine Against Myocardial Ischemia Injury and its Influence on Cardiomyocytes Apoptosis. Cell Biochemistry and Biophysics. 73(3). 707–716. 28 indexed citations
10.
Li, Shiqiang, Xianghua Fu, Chen Liu, et al.. (2015). [Effects of pretreatment with recombinant human B-type natriuretic peptide on infarct size in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention].. PubMed. 43(11). 954–9. 5 indexed citations
11.
Fu, Xianghua, Xuechao Wang, Xinshun Gu, et al.. (2012). Randomized comparison of radial versus femoral approach for patients with STEMI undergoing early PCI following intravenous thrombolysis.. PubMed. 24(8). 412–6. 62 indexed citations
12.
13.
Li, Wei, Xianghua Fu, Xuechao Wang, et al.. (2012). Efficacy and Safety of Standard‐Dose Versus Half‐Dose Tirofiban in Patients with Non‐ST Elevation Acute Coronary Syndromes Undergoing Early Percutaneous Coronary Intervention. Cardiovascular Therapeutics. 31(4). 210–214. 5 indexed citations
14.
Wang, Xuechao, Xianghua Fu, Xinwei Jia, et al.. (2011). Prediction of contrast-induced nephropathy in diabetics undergoing elective percutaneous coronary intervention: role of the ratio of contrast medium volume to estimated glomerular filtration rate.. PubMed. 124(6). 892–6. 14 indexed citations
15.
Fu, Xianghua, Xuechao Wang, Xinwei Jia, et al.. (2011). Protective Effects of Anisodamine on Renal Function in Patients with ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention. The Tohoku Journal of Experimental Medicine. 224(2). 91–97. 6 indexed citations
16.
Fu, Xianghua, Xinwei Jia, Xinshun Gu, et al.. (2010). B-type natriuretic peptide for prevention of contrast-induced nephropathy in patients with heart failure undergoing primary percutaneous coronary intervention. Acta Radiologica. 51(6). 641–648. 21 indexed citations
17.
Jia, Xinwei, Xianghua Fu, Jing Zhang, et al.. (2009). Comparison of Usefulness of Simvastatin 20 mg Versus 80 mg in Preventing Contrast-Induced Nephropathy in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention. The American Journal of Cardiology. 104(4). 519–524. 102 indexed citations
18.
Jia, Xinwei, Xianghua Fu, Jing Zhang, et al.. (2009). Intensive cholesterol lowering with statin improves the outcomes of percutaneous coronary intervention in patients with acute coronary syndrome.. PubMed. 122(6). 659–64. 20 indexed citations
19.
Fu, Xianghua, Xinwei Jia, Weize Fan, et al.. (2008). Effect of tirofiban plus clopidogrel and aspirin on primary percutaneous coronary intervention via transradial approach in patients with acute myocardial infarction. Chinese Medical Journal. 121(6). 522–527. 19 indexed citations
20.
Fan, Weize, Xianghua Fu, Yunfa Jiang, et al.. (2007). [Influence of intracoronary administration of anisodamine on no-reflow, ventricular function and systolic synchrony in acute myocardial infarction patients undergoing percutaneous coronary intervention].. PubMed. 35(10). 908–13. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xinshun Gu Breakdown of academic impact, for papers by Xianghua Fu Breakdown of academic impact, for papers by Hein A. Koomans Breakdown of academic impact, for papers by Catherine B. Brouwer Breakdown of academic impact, for papers by Xinwei Jia Breakdown of academic impact, for papers by Jean‐Luc Magnin Breakdown of academic impact, for papers by Abdullah Tekin Breakdown of academic impact, for papers by Priyanka Kakar Breakdown of academic impact, for papers by Silvio Fedele Breakdown of academic impact, for papers by Göknur Tekin
Rankless by CCL
2026